Moutzouri A G, Athanassiou G A, Dimitropoulou D, Skoutelis A T, Gogos C A
Department of Mechanical Engineering and Aeronautics, University of Patras, Rion-Patras, 26500 Patras, Greece.
J Infect. 2008 Aug;57(2):147-51. doi: 10.1016/j.jinf.2008.04.004. Epub 2008 May 27.
Diabetes mellitus is accompanied by microvascular complications leading to organ dysfunction, while sepsis is a major cause of morbidity and mortality in diabetics. We addressed the hypothesis that red blood cell (RBC) deformability may be additively compromised in septic diabetic patients, leading to a further impairment of microcirculation.
Forty patients suffering from severe sepsis, 12 patients suffering from diabetes and 24 diabetic patients with severe sepsis were enrolled. A filtration method and a hemorheometer were used to measure the RBCs' index of rigidity (IR).
We observed no differences in severity, organ dysfunction and outcome between diabetic and non-diabetic septic patients. Mean SAPS II score was 23.5% vs 26.8% in non-diabetic and diabetic septic patients, respectively. The mortality in non-diabetic septic patients was 22.5% and in septic diabetics was 34.3%, while septic shock occurred in 15.0% and 20.8%, respectively. We detected higher IR (17.72+/-6.31) in septic diabetics than in patients with diabetes and no sepsis (12.26+/-2.28, p< or =0.001) and in patients with sepsis and no diabetes (13.9+/-2.86, p< or =0.01).
The presence of diabetes mellitus seems to affect the already compromised RBC deformability of septic patients, probably leading to serious microcirculatory functional impairments in septic diabetic patients.
糖尿病常伴有微血管并发症,可导致器官功能障碍,而脓毒症是糖尿病患者发病和死亡的主要原因。我们探讨了脓毒症糖尿病患者的红细胞(RBC)变形能力可能会进一步受损,从而导致微循环进一步受损的假说。
纳入40例严重脓毒症患者、12例糖尿病患者和24例糖尿病合并严重脓毒症患者。采用过滤法和血液流变仪测量红细胞刚性指数(IR)。
我们观察到糖尿病和非糖尿病脓毒症患者在严重程度、器官功能障碍和预后方面无差异。非糖尿病和糖尿病脓毒症患者的平均急性生理与慢性健康状况评分系统II(SAPS II)分别为23.5%和26.8%。非糖尿病脓毒症患者的死亡率为22.5%,糖尿病脓毒症患者的死亡率为34.3%,而脓毒性休克的发生率分别为15.0%和20.8%。我们检测到糖尿病脓毒症患者的IR(17.72±6.31)高于糖尿病但无脓毒症患者(12.26±2.28,p≤0.001)和脓毒症但无糖尿病患者(13.9±2.86,p≤0.01)。
糖尿病的存在似乎会影响脓毒症患者本已受损的红细胞变形能力,这可能导致糖尿病脓毒症患者出现严重的微循环功能障碍。